Montreal, June 4, 2024 – ISOLOGIC Innovative Radiopharmaceuticals is investing $29.9 million to support the growth of the radiopharmaceutical industry and to reinforce its critical role in the field of nuclear medicine and the Canadian medical isotope supply chain as part of Quebec's life sciences ecosystem. Approximately $19 million will be devoted to the expansion [...]
Montreal, March 16th, 2023 – Isologic Innovative Radiopharmaceuticals is proud to announce that the prostate cancer imaging agent Illuccix®, Ga 68 Gozetotide Preparation Kit, also known as PSMA-11, is now available in Canada. 24,000 men are diagnosed with prostate cancer each year in Canada, making it the number one cancer among men. "Health Canada has [...]
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has signed a license and distribution agreement with Isologic Innovative Pharmaceuticals Ltd (Isologic) for the commercialisation of Telix’s investigational prostate cancer imaging agent, Illuccix® (kit for preparation of gallium Ga-68 gozetotide injection), also known as 68Ga-PSMA-11 injection, for the Canadian market. Please follow the link [...]
Our scientific event organized on June 13, 2022 during the SNMMI annual conference was a great success, We thank all the experts who accepted our invitation and took part in this seminar dedicated to PET imaging agents. Two international experts offered an overview of prostate and brain cancer imaging to our 150 participants. Pictures : [...]
PRODUCT UPDATE - January 10th, 2019 MONTREAL, January 10th, 2019 Dear Customer, We would like to inform you of our I-131 Dx capsule supply. We will have 100 μCi diagnostic capsules available on January 21st. These capsules will have a calibration date of January 23rd. We also have [...]
PRODUCT UPDATE - DECEMBER 20th, 2018 MONTREAL, DEC. 20th, 2018 Dear Customer, We would like to inform you that due to an unforeseeable I-131 Dx capsule production issue we will not be able to produce and ship I-131 Dx capsule for an undetermined period of time. We have [...]
PIRAMAL IMAGING SA AND ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ANNOUNCE COMMERCIAL APPROVAL OF NEURACEQ™ BY HEALTH CANADA MONTREAL, Feb. 28, 2017 /CNW Telbec Piramal Imaging SA and ISOLOGIC Innovative Radiopharmaceuticals today announce that Health Canada has issued a Notice of Compliance (NOC) to ISOLOGIC Innovative Radiopharmaceuticals for [...]
IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic signed an exclusive agreement for the distribution of Galli Eo™ 68Ge/ 68Ga generator in Canada FLEURUS, Belgium ; Montreal, Canada ; the 31st January. IRE-ELiT S.A. (Environment & Lifescience Technology) & Isologic Innovative Radiopharmaceuticals, the Canadian leader in radiopharmacy servicess [...]
Statement on Reports of a Medical Isotope Shortage Recently, there has been several public announcements in print and on Canadian television & radio regarding an upcoming shortage in the supply of medical isotopes. In these reactionary articles, while based on the closure of Canada’s NRU reactor, [...]
ISOLOGIC Acquires Lantheus Canadian Imaging Centres ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS ACQUIRES LANTHEUS MEDICAL IMAGING CANADIAN RADIOPHARMACEUTICAL CENTRES ISOLOGIC is pleased to announce the completion of an asset purchase agreement for the acquisition of the Canadian radiopharmacy and Gludef manufacturing and distribution business operations of Lantheus [...]
